The Impact of Cigarette Smoking on Stimulant Addiction

REFERENCES

• Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2005 National Survey on Drug Use and Health: National findings. SAbuseMHSA, Rockville, MD 2006, (DHHS Publication No. SMA 06-4194, NSDUH Series H-30)
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2003 National Survey on Drug Use and Health: National findings. SAMHSA, Rockville, MD 2004, (DHHS Publication No. SMA 04-3964, NSDUH Series H-25)
   Google Scholar
• Kalman D, Morrisette S B, George T P. Co-morbidity of smoking with psychiatric and substance use disorders. American Journal on Addictions 2005; 14(2)106–123
   PubMed Web of Science ®Google Scholar
• Lasser K, Boyd J W, Woolhander S, Himmelstein D U, McCormick D, Bor D H. Smoking and mental illness: a population-based prevalence study. Journal of the American Medical Association 2000; 284: 2606–2610
   PubMed Web of Science ®Google Scholar
• Budney A J, Higgins S T, Hughes J R, Bickel W K. Nictotine and caffeine use in cocaine-dependent individuals. Journal of Substance Abuse 1993; 5(2)117–130
   PubMedGoogle Scholar
• Patkar A A, Lundy A, Lenoe F T, Weinstein S P, Gottheil E, Steinberg M. Tobacco and alcohol use and medical symptoms among cocaine dependent patients. Substance Abuse 2002; 23(2)105–114
   PubMedGoogle Scholar
• Gorelick D A, Simmons M S, Carriero N, Tashkin D P. Characteristics of smoked drug use among cocaine smokers. American Journal of Addictions 1997; 6: 237–245
   PubMed Web of Science ®Google Scholar
• Patkar A A, Mannelli P, Peindl K, Murray H W, Meier B, Leone F T. Changes in tobacco smoking following treatment for cocaine dependence. The American Journal of Drug and ALcohol Abuse 2006; 32: 135–148
   PubMed Web of Science ®Google Scholar
• Grant B F, Hasin D S, Chou P, Stinson F S, Dawson D A. Nicotine dependence and psychiatric disorders in the United States. Archives of General Psychiatry 2004; 61: 1107–1115
   PubMed Web of Science ®Google Scholar
• Grant K M, Kelley S S, Agrawal S, Meza J L, Meyer J R, Romberger D J. Methamphetamine use in rural midwesterners. The American Journal on Addictions 2007; 16: 79–84
   PubMed Web of Science ®Google Scholar
• Martin I, Lampinen T M, McGhee D. Methamphetamine use among marginalized youth in British Columbia. Canadian Journal of Public Health 2006; 97(4)320–324
   PubMed Web of Science ®Google Scholar
• Yen C F, Chong M Y. Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: A case-control study. Comprehensive Psychiatry 2006; 47(3)215–220
   PubMed Web of Science ®Google Scholar
• Brecht M-L, Greenwell L, Anglin M D. Substance use pathways to methamphetamine use among treated users. Addictive Behaviors 2007; 32: 24–28
   PubMed Web of Science ®Google Scholar
• Baker A, Lee N K, Claire M, Lewin T J, Grant T, Pohlman S, et al. Drug use patterns and mental health of regular amphetamine users during a reported ‘heroin drought.’. Addiction 2004; 99: 875–884
   PubMed Web of Science ®Google Scholar
• Kandel D, Faust R. Sequence and stages in patterns of adolescent drug use. Archives of General Psychiatry 1975; 32(7)923–932
   PubMed Web of Science ®Google Scholar
• Kandel D B, Logan J A. Patterns of drug use from adolescence to young adulthood: I. Periods of risk for initiation, continued use, and discontinuation. American Journal of Public Health 1984; 74(7)660–666
   PubMed Web of Science ®Google Scholar
• Chen K, Kandel D B. The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health 1995; 85(1)41–47
   PubMed Web of Science ®Google Scholar
• Lindsay G B, Rainey J. Psychosocial and pharmacologic explanations of nicotine's “gateway drug” function. Journal of School Health 1997; 67(4)123–126
   PubMed Web of Science ®Google Scholar
• Slotkin T A. Nicotine and the adolescent brain: insights from an animal model. Neurotoxicology and Teratology 2002; 24(3)369–384
   PubMed Web of Science ®Google Scholar
• Fagen Z M, Mitchum R, Vezina P, McGehee D S. Enhanced nicotinic receptor function and drug abuse vulnerability. Journal of Neuroscience 2007; 27(33)8771–8778
   PubMed Web of Science ®Google Scholar
• McQuown S C, Belluzzi J D, Leslie F M. Low dose nicotine treatment during early adolescence increases subsequent cocaine reward. Neurotoxicology and Teratology 2007; 29(1)66–73
   PubMed Web of Science ®Google Scholar
• Nolley E P, Kelley B M. Adolescent reward system perseveration due to nicotine: Studies with methylphenidate. Neurotoxicology and Teratology 2007; 29(1)47–56
   PubMed Web of Science ®Google Scholar
• Koob G F. Neural mechanisms of drug reinforcement. Ann N Y Acad Sci 1992; 654: 171–191
   PubMed Web of Science ®Google Scholar
• Kahlig K M, Binda F, Khoshbouei H, Blakely R D, McMahon D G, Javitch J A, Galli A. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proceedings of the National Academy of Sciences of the United States of America 2005; 102(9)3495–3500
   PubMed Web of Science ®Google Scholar
• Dani J A, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology 2007; 47: 699–729
   PubMed Web of Science ®Google Scholar
• Clader J W, Wang Y. Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease. Current Pharmaceutical Design 2005; 11(26)3353–3361
   PubMed Web of Science ®Google Scholar
• Picciotto M R, Corrigall W A. Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. Journal of Neuroscience 2002; 22(9)3338–3341
   PubMed Web of Science ®Google Scholar
• Picciotto M R, Zoli M, Lena C, Bessis A, Lallemand Y, Le Novere N, Vincent P, Pich E M, Brulet P, Changeux J P. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 1995; 374(6517)65–67
   PubMed Web of Science ®Google Scholar
• Gotti C, Riganti L, Vailati S, Clementi F. Brain neuronal nicotinic receptors as new targets for drug discovery. Current Pharmaceutical Design 2006; 12(4)407–428
   PubMed Web of Science ®Google Scholar
• Roll J M, Higgins S T, Budney A J, Bickel W K, Badger G J. A comparison of cocaine-dependent cigarette smokers and non-smokers on demographic, drug use and other characteristics. Drug and Alcohol Dependence 1996; 40(3)195–201
   PubMed Web of Science ®Google Scholar
• Krejci J, Steinberg M L, Ziedonis D. Smoking status and substance abuse severity in a residential treatment sample. Drug and Alcohol Dependence 2003; 72(3)249–254
   PubMed Web of Science ®Google Scholar
• Meier B R, Lundy A, Patkar A A, Weinstein S. The relationship between nicotine dependence and addiction severity amongst cocaine abusers. Journal of Substance Use 2005; 10(5)303–314
   Google Scholar
• McLellan A T, Luborsky L, Cacciola M A, Griffith B A, Evans F, Barr H L. New data from the Addcition Severity Index: Reliability and validity in three centers. Journal of Nervous and Mental Disease 1985; 173: 412–423
   PubMed Web of Science ®Google Scholar
• Patkar A A, Vergare M J, Thornton C C, Weinstein S P, Murray H W, Leone F T. Nicotine dependence and treatment outcome among African American cocaine-dependent patients. Nicotine and Tobacco Research 2003; 5: 411–418
   PubMed Web of Science ®Google Scholar
• Polling J, Kosten T R, Sofuoglu M. Treatment outcome predictors for cocaine dependence. The American Journal of Drug and Alcohol Abuse 2007; 33: 191–206
   PubMed Web of Science ®Google Scholar
• Carroll K M, Power M E, Bryant K, Rounsaville B J. One-year follow-up status of treatment-seeking cocaine abusers: Psychopathology and dependence severity as a predictor of outcome. Journal of Nervous and Mental Disease. 1993; 181(2)71–79
   PubMed Web of Science ®Google Scholar
• Verdejo-Garcia A, Benbrook A, Funderburk F, David P, Cadet J-L, Bolla K I. The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing on the iowa gambling task. Drug and Alcohol Dependence 2007a; 90: 2–11
   PubMed Web of Science ®Google Scholar
• Verdejo-Garcia A J, Perales J C, Perez-Garcia M. Cognitive impulsivity in cocaine and heroine polysubstance abusers. Addictive Behaviors 2007b; 32: 950–966
   PubMed Web of Science ®Google Scholar
• Ersche K D, Sahakian B J. The neuropsychology of amphetamine and opiate dependence: Implications for treatment. Neuropsychology Review 2007; 17: 317–336
   PubMed Web of Science ®Google Scholar
• Scott J C, Woods S P, Matt G E, Meyer R A, Heaton R K, Atkinson J H, Grant I. Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychology Review 2007; 17: 275–297
   PubMed Web of Science ®Google Scholar
• Aharonovich E, Hasin D S, Brooks A C, Liu X, Bisaga A, Nunes E V. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and Alcohol Dependence 2006; 81: 313–322
   PubMed Web of Science ®Google Scholar
• Aharonovich E, Nunes E, Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug and Alcohol Dependence 2003; 71: 207–211
   PubMed Web of Science ®Google Scholar
• Verdejo-Garcia A, Lopez-Torrecillas F, Gimenez C O, Perez-Garcia M. Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychology Review 2004; 14(1)1–41
   PubMed Web of Science ®Google Scholar
• Levin E D, McClernon F J, Rezvani A H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology 2006; 184(3–4)523–539
   PubMed Web of Science ®Google Scholar
• Rotheram-Fuller E, Shoptaw S, Berman S M, London E D. Impaired performance in a test of decision-making by opiate-dependent tobacco smokers. Drug and Alcohol Dependence 2004; 73: 79–86
   PubMed Web of Science ®Google Scholar
• Giovino G A. Epidemiology of tobacco use in the United States. Oncogene 2002; 21: 7326–7340
   PubMed Web of Science ®Google Scholar
• SAMHSA. Drug Abuse Warning Network, 2003: Area Profiles of Drug-Related Mortality. Substance Abuse and Mental Health Services Administration, Rockville, MD 2005
   Google Scholar
• Barr H L, Antes D, Ottenberg D J, Rosen A. Mortality of treated alcoholics and drug addicts: The benefits of abstinence. Journal of Studies on Alcohol 1984; 45(5)440–452
   PubMed Web of Science ®Google Scholar
• Cherubin C E, Sapria J D. The medical complications of drug addiction and the medical assessment of intravenous drug abuser: 25 years later. Annals of Internal Medicine 1993; 119: 1017–1028
   PubMed Web of Science ®Google Scholar
• Garrity T F, Leukefeld C G, Carlson R G, Falck R S, Wang J, Booth B M. Physical health, illicit drug use, and demographic characteristics in rural stimulant users. The Journal of Rural Health 2007; 23(2)99–107
   PubMed Web of Science ®Google Scholar
• Patkar A A, Batra V, Mannelli P, Evers-Casey S, Vergare M J, Leone F T. Medical symptoms associated with tobacco smoking with and without marijuana abuse among crack cocaine-dependence patients. American Journal on Addictions 2005; 43–53
   PubMed Web of Science ®Google Scholar
• Hurt R D, Offord K P, Croghan I T, Gomez-Dahl L, Kottke T E, Morse R M, Melton L J. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. J. Am. Med. Assoc. 1996; 275(14)1097–1103
   PubMed Web of Science ®Google Scholar
• Hser Y I, McCarthy W J, Anglin M D. Tobacco use as a distal predictor of mortality among long-term narcotic addicts. Preventative Medicine 1994; 23: 61–69
   PubMed Web of Science ®Google Scholar
• Abreu-Villaca Y, Seidler F J, Qiao D, Tate C A, Cousins M M, Thillai I, Slotkin T A. Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: Critical periods, patterns of exposure, dose thresholds. Neuropsychopharmacology 2003; 28(11)1935–1949
   PubMed Web of Science ®Google Scholar
• Abreu-Villaca Y, Seidler F J, Tate C A, Slotkin T. Impact of adolescent nicotine exposure on adenylyl cyclase-mediated cell signaling: enzyme induction, neurotransmitter-specific effects, regional selectivities, and the role of withdrawal. Brain Research 2003; 988(1–2)163–172
   Web of Science ®Google Scholar
• Slotkin T A, Cousins M M, Seidler F J. Administration of nicotine to adolescent rats evokes regionally selective upregulation of CNS alpha 7 nicotinic acetylcholine receptors. Brain Research 2004; 1030(1)159–163
   PubMed Web of Science ®Google Scholar
• Adriani W, Deroche-Gamonet V, Le Moal M, Laviola G, Piazza P V. Preexposure during or following adolescence differently affects nicotine-rewarding properties in adult rats. Psychopharmacology 2006; 184(3–4)382–390
   PubMed Web of Science ®Google Scholar
• Collins S L, Izenwasser S. Chronic nicotine differentially alters cocaine-induced locomotor activity in adolescent vs. adult male and female rats. Neuropharmacology 2004; 46(3)349–362
   PubMed Web of Science ®Google Scholar
• de Rover M, Lodder J C, Kits K S, Schoffelmeer A N, Brussaard A B. Cholinergic modulation of nucleus accumbens medium spiny neurons. European Journal of Neuroscience 2002; 16(12)2279–2290
   PubMed Web of Science ®Google Scholar
• Cragg S J. Meaningful silences: How dopamine listens to the ACh pause. Trends in Neuroscience 2006; 29(3)125–131
   PubMed Web of Science ®Google Scholar
• Lambert N M, McLeod M, Schenk S. Subjective responses to initial experience with cocaine: An exploration of the incentive-sensitation theory of drug abuse. Addiction 2006; 101: 713–725
   PubMed Web of Science ®Google Scholar
• Hikida T, Kaneko S, Isobe T, Kitabatake Y, Watanabe D, Pastan I, Nakanishi S. Increased sensitivity to cocaine by cholinergic cell ablation in nucleus accumbens. Proceedings of the National Academy of Sciences of the United States of America 2001; 98(23)13351–13354
   PubMed Web of Science ®Google Scholar
• Takamatsu Y, Yamanishi Y, Hagino Y, Yamamoto H, Ikeda K. Differential effects of donepezil on methamphetamine and cocaine dependencies. Annals of the New York Academy of Sciences 2006; 1074: 418–426
   PubMed Web of Science ®Google Scholar
• Hiranita T, Nawata Y, Sakimura K, Anggadiredja K, Yamamoto T. Suppression of methamphetamine-seeking behavior by nicotinic agonists. Proceedings of the National Academy of Sciences of the United States of America 2006; 103(22)8523–8527
   PubMed Web of Science ®Google Scholar
• Crespo J A, Sturm K, Saria A, Zernig G. Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement. Journal of Neuroscience 2006; 26(22)6004–6010
   PubMed Web of Science ®Google Scholar
• Bechtholt A J, Mark G P. Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats. Psychopharmacology (Berl) 2002; 162: 178–185
   PubMed Web of Science ®Google Scholar
• Hansen S T, Mark G P. The nicotinic acetylcholine receptor antagonist mecamylamine prevents escalation of cocaine self-administration in rats with extended daily access. Psychopharmacology (Berl) 2007; 194(1)53–61
   PubMed Web of Science ®Google Scholar
• Reid M S, Mickalian J D, Delucchi K L, Hall S M, Berger S P. An acute dose of nicotine enhances cue-induced cocaine craving. Drug and Alcohol Dependence 1998; 49: 95–104
   PubMed Web of Science ®Google Scholar
• Kouri E M, Stull M, Lukas S E. Nicotine alters some of cocaine's subjective effects in the absence of physiological or pharmacokinetic changes. Pharmacology, Biochemistry, and Behavior 2001; 69: 209–217
   PubMed Web of Science ®Google Scholar
• Sobel B-FX, Sigmon S C, Griffiths R R. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous ncitoine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers. Neuropsychopharmacology 2004; 29: 991–1003
   PubMed Web of Science ®Google Scholar
• Campbell B K, Wander N, Stark M J, Holbert T. Treating cigarette smoking in drug-abusing clients. Journal of Substance Abuse Treatment 1995; 12(2)89–94
   PubMed Web of Science ®Google Scholar
• Sees K L, Clark H W. Substance abusers want to stop smoking!. Alsam Clin. Exp. Res. 1991; 15: 152
   Google Scholar
• Radzius A, Gorelick D A, Henningfield J E. Cigarette smoking during early cocaine abstinence. American Journal on Addictions 1998; 7(4)305–308
   PubMed Web of Science ®Google Scholar
• Baker A, Lee N K, Claire M, Lewin T J, Grant T, Pohlman S, et al. Brief cognitive behavioural interventions for regular amphetamine users: A step in the right direction. Addiction 2005; 100: 367–378
   PubMed Web of Science ®Google Scholar
• Grand R BG, Hwang S, Han J, George T P, Brody A L. Short-term naturalistic treatment outcomes in cigarette smokers with substance abuse and/or mental illness. Journal of Clinical Psychiatry 2007; 68(6)892–898
   PubMed Web of Science ®Google Scholar
• Weinberger A H, Reutenauer E L, Vessicchio J C, George T P. Survey of clinician attitudes toward smoking cessation for psychiatric and substance abusing clients. Journal of Addictive Diseases 2008; 27(1)55–63
   PubMed Web of Science ®Google Scholar
• Burling T A, Burling A S, Latini D. A controlled smoking cessation trial for substance-dependent inpatients. J. Consult. Clin. Psychology 2001; 69: 295–304
   Google Scholar
• Kalman D, Kahler C, Tirch D, Penk W, Kaschib C, Monti P M. Twelve-week outcomes from an investigation of high dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence. Psychol. Addict. Behav. 2004; 18(1)78–82
   Google Scholar
• Kalman D, Hayes K, Colby S M, Eaton C A, Rohsenow D J, Monti P M. Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery. A pilot study. Journal of Substance Abuse Treatment 2001; 20(3)233–238
   PubMed Web of Science ®Google Scholar
• Hurt R D, Eberman K M, Croghan I T, Gomez-Dahl L, Kotkke T E, Morse R M, Melton L J. Nicotine dependence treatment during inpatient treatment for other addictions: A prospective intervention trial. Alcoholism: Clinical and Experimental Research 1994; 18(4)867–872
   PubMed Web of Science ®Google Scholar
• Joseph A. Nicotine treatment at the drug dependency program of the minneapolis VA medical center. Journal of Substance Abuse Treatment 1993; 10: 147–152
   PubMed Web of Science ®Google Scholar
• Bobo J K, McIlvain H E, Lando H A, Walker R D, Leed-Kelly A. Effects of smoking cessation counseling on recovery from alcoholism: Findings from a randomized community intervention trial. Addiction 1998; 93: 877–887
   PubMed Web of Science ®Google Scholar
• Joseph A M, Willenbring M L, Nugent S M, Nelson D B. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. Journal of Studies on Alcohol 2004; 65: 681–691
   PubMed Web of Science ®Google Scholar
• Sofuoglu M, Poling J, Gonzalez G, Gonsai K, Kosten T. Cocaine withdrawal symptoms predict medication response in cocaine users. The American Journal of Drug and Alcohol Abuse 2006; 32: 617–627
   PubMed Web of Science ®Google Scholar
• Grassi M C, Cioce A M, Antonilli L, Nencini P. Short-term efficacy of disulfiram or naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: A pilot study. Pharmacological Research 2007; 55(2)117–121
   PubMed Web of Science ®Google Scholar
• Oliveto A, Poling J, Sevarino K A, Gonsai K R, McCance-Katz E F, Stine S M, Kosten T R. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug and Alcohol Dependence 2005; 79(2)137–165
   PubMed Web of Science ®Google Scholar
• Stotts A L, Potts G F, Ingersoll G, George M R, Martin L E. Preliminary feasibility and efficacy of a brief motivational intervention with psychophysiological feedback for cocaine abuse. Substance Abuse 2006; 27(4)9–20
   PubMedGoogle Scholar
• Stoptaw S, Jarvik M E, Ling W, Rawson R A. Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addictive Behaviors 1996; 21(3)409–412
   PubMed Web of Science ®Google Scholar